We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00599768
Recruitment Status : Completed
First Posted : January 24, 2008
Last Update Posted : November 23, 2009
Information provided by:

Study Description
Brief Summary:
This prospective cohort and multi-site study aims to develop Taiwan version (ID Pain-T) based on the original versions of ID Pain and also DN4, and validate both ID Pain-T and DN4 applied in Taiwanese subjects at the clinical setting.

Condition or disease Intervention/treatment
Neuralgia Nerve Pain Neuropathic Pain Other: ID-Pain DN4 Questionnaire

Study Design

Study Type : Observational
Actual Enrollment : 325 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.
Study Start Date : March 2008
Primary Completion Date : December 2008
Study Completion Date : December 2008
Groups and Cohorts

Intervention Details:
    Other: ID-Pain DN4 Questionnaire
    This is a non-interventional questionnaire validation study

Outcome Measures

Primary Outcome Measures :
  1. Determine the optimal cut-off score of ID Pain-T Questionnaire for screening of neuropathic pain [ Time Frame: end of study ]

Secondary Outcome Measures :
  1. Evaluate the predictive power of ID Pain-T Questionnaire for diagnosis of neuropathic pain [ Time Frame: end of study ]
  2. Develop and evaluate validity of a short form diagnostic tool based on DN4 structure [ Time Frame: end of study ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients of non-headache pain for more than 30 days and those whose age is more than 18 years old

Inclusion Criteria:

  • Subjects without headache pain over 30 days and at least 18 years old who will visit the clinic, inclusive of male and female.
  • Subjects who are able to complete the ID Pain-T Questionnaire.

Exclusion Criteria:

  • Subjects who are illiterate or unable to complete questionnaire.
  • Subjects who are currently participating in another study or have participated in another pain study within one month of study entry.
  • Subjects with low back pain are unable to participate in this study; as the sciatica caused by the piriformis (exclusive of the other types of sciatic pain), lumbago, unclear identification in nerve injury (e.g. complex regional pain syndrome type I) or mixed origin (e.g. cancer pain).
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00599768

Sponsors and Collaborators
Study Director: Pfizer CT.gov Call Center Pfizer
More Information

Additional Information:
Responsible Party: Director, Clinical Trials Disclosure Group, Pfizer, Inc.
ClinicalTrials.gov Identifier: NCT00599768     History of Changes
Other Study ID Numbers: A0081175
First Posted: January 24, 2008    Key Record Dates
Last Update Posted: November 23, 2009
Last Verified: November 2009

Additional relevant MeSH terms:
Neurologic Manifestations
Nervous System Diseases
Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms